¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"antigenic reversion"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic reversion
    Ç׿øº¹±Í
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reversion
    1. º¹±Í 2. Àüȯ 3. º¹±Íµ¹¿¬º¯ÀÌ
  • sexual reversion
    ¼ºÀüȯ
  • antigenic deletion
    Ç׿ø°á¼Õ
  • antigenic determinant
    Ç׿ø°áÁ¤ÀÎÀÚ
  • antigenic diversion
    Ç׿øÀüȯ
  • antigenic drift
    Ç׿øº¯ÀÌ
  • antigenic profile
    Ç׿øÇÁ·ÎÇÊ
  • antigenic shift
    Ç׿øº¯À§
  • antigenic specificity
    Ç׿øÆ¯À̼º
  • antigenic stimulation
    Ç׿øÀÚ±Ø
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reversion
    º¹±Í
  • sexual reversion
    ¼ºÀüȯ
  • antigenic determinant
    Ç׿ø°áÁ¤±â
  • antigenic specificity
    Ç׿øÆ¯À̼º
  • antigenic stimulation
    Ç׿øÀÚ±Ø
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic reversion
    Ç׿øº¹±Í
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reversion
    º¹±Í
  • sexual reversion
    ¼ºÀüȯ
  • antigenic deletion
    Ç׿ø°á¼Õ
  • antigenic determinant
    Ç׿ø°áÁ¤±â
  • antigenic diversion
    Ç׿øÀüȯ
  • antigenic drift
    Ç׿ø¼ÒÆøº¯ÀÌ
  • antigenic profile
    Ç׿øÇÁ·ÎÇÊ
  • antigenic shift
    Ç׿øº¯À§
  • antigenic specificity
    Ç׿øÆ¯À̼º
  • antigenic stimulation
    Ç׿øÀÚ±Ø
  • antigenic transformation
    Ç׿øº¯È¯
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic reversion
    Ç׿øº¹±Í(ù÷ê«ÜÖÏý).
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic
    Ç׿ø¼º(¡­àõ)(ÀÇ).
  • antigenic
    Ç׿ø¼º(ÀÇ)
  • antigenic assay
    Ç׿ø¼ººÐ¼®
  • antigenic competition
    Ç׿ø°æÀï
  • antigenic deletion
    Ç׿ø°á½Ç(ù÷ê«ÌÀã÷).
  • antigenic determinant
    Ç׿ø°áÁ¤±â(¡­Ì½ïÒÐñ).
  • antigenic determinant
    Ç׿ø°áÁ¤±â(¡­Ì½ïÒÐñ).
  • antigenic determinant
    Ç׿ø°áÁ¤±â(¡­Ì½ïÒÐñ).
  • antigenic diversion
    Ç׿øÀüȯ(ù÷ê«ï®üµ).
  • antigenic drift
    Ç׿ø¼Òº¯ÀÌ
  • antigenic drift, influenza viruses
    Ç׿ø¼Òº¯ÀÌ(ù÷ê«á³Ü¨ì¶)
  • antigenic mimicry
    Ç׿øÀ¯»ç¼º
  • antigenic profile
    Ç׿ø(ù÷ê«)ÇÁ·ÎÇÊ.
  • antigenic shift
    Ç׿ø´ëº¯ÀÌ
  • antigenic shift
    Ç׿øº¯ÀÌ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic reversion
    Ç׿øº¹±Í(ù÷ê«ÜÖÏý).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • electrical reversion of cardiac arrhythmia
    ½ÉºÎÁ¤¸ÆÀÇ Àü±âÀû ¹ÝÀü(ãýÝÕïÚØæ¡­Úãï®).
  • sexual reversion
    ¼ºÀüȯ(àõï®üµ).
  • antigenic
    Ç׿ø¼º(¡­àõ)(ÀÇ).
  • antigenic
    Ç׿ø¼º(ÀÇ)
  • antigenic assay
    Ç׿ø¼ººÐ¼®
  • antigenic competition
    Ç׿ø°æÀï
  • antigenic deletion
    Ç׿ø°á½Ç(ù÷ê«ÌÀã÷).
  • antigenic determinant
    Ç׿ø°áÁ¤±â(¡­Ì½ïÒÐñ).
  • antigenic determinant
    Ç׿ø°áÁ¤±â(¡­Ì½ïÒÐñ).
  • antigenic determinant
    Ç׿ø°áÁ¤±â(¡­Ì½ïÒÐñ).
  • antigenic diversion
    Ç׿øÀüȯ(ù÷ê«ï®üµ).
  • antigenic drift
    Ç׿ø¼Òº¯ÀÌ
  • antigenic drift, influenza viruses
    Ç׿ø¼Òº¯ÀÌ(ù÷ê«á³Ü¨ì¶)
  • antigenic mimicry
    Ç׿øÀ¯»ç¼º
  • antigenic profile
    Ç׿ø(ù÷ê«)ÇÁ·ÎÇÊ.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • enzymatic reversion
    È¿¼Ò º¹±Í(ý£áÈÜÖÏý)
  • genetic reversion
    À¯Àü º¹±Í(ë¶îîÜÖÏý)
  • reversion
    º¹±Í(ÜÖÏý)
  • reversion index
    º¹±Í Áö¼ö(ò¦â¦)
  • reversion spectroscope
    º¹±Í ºÐ±¤°è(ÝÂÎÃͪ)
  • second-site reversion
    µÑ° ÀÚ¸® º¹±Í(ÜÖÏý)
  • antigenic competition
    Ç׿ø°æÇÕ(ù÷ê«Ìæùê)
  • antigenic conversion
    Ç׿øÀüȯ(ù÷ê«ï®üµ)
  • antigenic deletion
    Ç׿ø°á¼Õ(ù÷ê«ÌÀáß)
  • antigenic determinant
    Ç׿ø°áÁ¤¼Ò(ù÷ê«Ì½ïÒáÈ)
  • antigenic drift
    Ç׿ø¼º Ç¥·ù(ù÷ê«àõø÷×µ)
  • antigenic gain
    Ç׿ø¼º Áõ°¡(ù÷ê«àõñòÊ¥)
  • antigenic modulation
    Ç׿øÁ¶Á¤(ù÷ê«ðàïÚ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
MAD Major Antigenic Determinant
AD accident dispensary; acetate dialysis; active disease; acute dermatomyositis; addict, addiction; ade...
NAD neutrophil actin dysfunction; new antigenic determinant; nicotinamide adenine dinucleotide; nicotini...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
MAP Multiple Antigenic Peptide
VAT variant antigenic type
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • antigenic assay
    Ç׿ø¼º ºÐ¼®
  • antigenic specificity
    Ç׿ø ƯÀ̼º
  • antigenic suicide
    Ç׿ø¿¡ ÀÇÇÑ ¸²ÇÁ±¸ÀÇ ÀÚ¸ê
    °íµµ·Î ¹æ»ç Ȱ¼ºÀÌ ÀÖ´Â Ç׿øÀ» »ýü¿¡ Åõ¿©Çϸé ÀÌ Ç׿ø¿¡ ´ëÇÏ¿© °¨¼ö¼ºÀÌ ÀÖ´Â ¸²ÇÁ±¸´Â °¨¼Ò ³»Áö ºÒȰ¼ºÈ­µÇ¾î ¹ö¸°´Ù. µû¶ó¼­ ¹æ»ç Ȱ¼ºÀÌ ¾ø´Â °°Àº Ç׿øÀ» Åõ¿©Çصµ ÀÌ Ç׿ø¿¡ ƯÀÌÀûÀÎ ¸é¿ª ÀÀ´äÀº »ý±âÁö ¾Ê°Ô µÈ´Ù. À̰ÍÀº Ç׿ø¿¡ ¹ÝÀÀÇÏ´Â ¸²ÇÁ±¸°¡ ¹æ»ç Ȱ¼ºÀÌ ÀÖ´Â Ç׿øÀ» °áÇÕ½ÃÅ´À¸·Î½á ¹æ»ç´É¿¡ ÀÇÇÑ ¼¼Æ÷ ¼Õ»óÀ» ÀԾ ¾ß±âµÇ´Â °ÍÀÌ´Ù. À̰ÍÀ» Ç׿ø¿¡ ÀÇÇÑ ¸²ÇÁ±¸ÀÇ ÀÚ¸êÀ̶ó°í ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
reversion <molecular biology> Reversion of a mutation occurs when a second mutation restores the function that was lost as a result of the first mutation. The second mutation causes a change in the DNA that either reverses the original alteration or compensates for it.
(18 Nov 1997)
antigenic Having the properties of an antigen (allergen).
Synonym: allergenic, immunogenic.
(05 Mar 2000)
antigenic competition Competition that occurs when two different antigens, each of which can evoke an immunological response when inoculated alone, are mixed in equal quantities and inoculated together; the response may be to only one, that to the other being largely or entirely suppressed.
(05 Mar 2000)
antigenic complex A composite of different antigenic structures, such as a cell or a bacterium, or, by extension, a molecule containing two or more determinant groups of different antigenic specificities.
(05 Mar 2000)
antigenic determinant That part of an antigenic molecule against which a particular immune response is directed. For instance a tetra to penta peptide sequence in a protein, a tri to penta glycoside sequence in a polysaccharide.
In the animal most antigens will present several or even many antigenic determinants simultaneously.
See: hapten.
(18 Nov 1997)
antigenic drift <immunology> A change that occurs on the molecular level to effect a change in the antigenicity of a bacteria or virus. Antigenic drift occurs naturally and more rapidly in certain viruses (for example HIV). It is antigenic drift which complicates the development of an effective HIV (AIDS) vaccine.
(27 Sep 1997)
antigenic modulation Loss of detectable antigen from the surface of a cell after incubation with antibodies. This is one method in which some tumours escape detection by the immune system. Antigenic modulation of target antigens also reduces the therapeutic effectiveness of treatment by monoclonal antibodies.
(12 Dec 1998)
antigenic shift Mutation, i.e., sudden change in molecular structure of RNA/DNA in microorganisms, especially viruses, which produces new strains of the microorganism; hosts previously exposed to other strains have little or no acquired immunity to the new strain; antigenic shift is believed to be the explanation for the occurrence of strains of microorganisms, such as the influenza virus, associated with large scale epidemics.
(05 Mar 2000)
antigenic switching <immunology> The process by which a pathogenic microbe's genetic structure is altered tochange its surface antigens inorder to avoid being detected by the host's immune system.
(09 Oct 1997)
antigenic variation The phenomenon of changes in surface antigens in parasitic populations of Trypanosoma and Plasmodium (and some other parasitic protozoa) in order to escape immunological defense mechanisms. at least 100 different surface proteins have been found to appear and disappear during antigenic variation in a clone of trypanosomes. Each antigen is encoded in a separate gene. Antigenic variation is also known to occur in free living Protozoa and certain bacteria.
(18 Nov 1997)
idiotypic antigenic determinant The antigenic specificites defined by the unique sequences (idiotopes) of the antigen combining site. Thus anti-idiotype antibodies combine with those specific sequences, may block immunological reactions and may resemble the epitope to which the first antibody reacts.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reversion
    µÇµ¹¾Æ°¡±â
  • reversion
    µÇµ¹¾Æ°¨;(¿ø·¡»óÅ·ÎÀÇ)º¹±Í;°Ý¼¼À¯Àü;ȯ¿øÀ¯Àü;Àüµµ;¿ªÀü;Àüȯ;Àç»êÀÇ º¹±Í;º¹±ÍÀç»ê;°è½Â(»ó¼Ó)±Ç;º¹±Í±Ç;Àå·¡(ƯÈ÷ Á×Àº ÈÄ¿¡)ÁöºÒ¹ÞÀ» µ·(¿¬±Ý.»ý¸í º¸Çèµî);ÀåÂ÷ ÇâÀ¯ÇÒ ±Ç¸®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á